Real‐world data prognostic model of overall survival in patients with advanced NSCLC receiving anti‐PD‐1/PD‐L1 immune checkpoint inhibitors as second‐line monotherapy

BACKGROUND AND AIM: The objective of this retrospective, observational, noninterventional cohort study was to investigate prognostic factors of overall survival (OS) in patients with advanced non‐small cell lung cancer (aNSCLC) and to develop a novel prognostic model. METHODS: A total of 4049 patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Julian, Cristina, Machado, Robson J. M., Girish, Sandhya, Chanu, Pascal, Heinzmann, Dominik, Harbron, Chris, Gershon, Anda, Pfeiffer, Shannon M., Zou, Wei, Quarmby, Valerie, Zhang, Qing, Chen, Yachi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575492/
https://www.ncbi.nlm.nih.gov/pubmed/35075804
http://dx.doi.org/10.1002/cnr2.1578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575492/
https://www.ncbi.nlm.nih.gov/pubmed/35075804
http://dx.doi.org/10.1002/cnr2.1578

Ejemplares similares